Entity Common Stock, Shares Outstanding of Regen BioPharma Inc from Q1 2014 to Q2 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Regen BioPharma Inc quarterly Entity Common Stock, Shares Outstanding history and change rate from Q1 2014 to Q2 2025.
  • Regen BioPharma Inc Entity Common Stock, Shares Outstanding for the quarter ending 30 Jun 2025 was 31.6M shares, a 600% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Regen BioPharma Inc Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 31.6M +27M +600% 30 Jun 2025 10-Q 11 Aug 2025
Q2 2025 21.6M +17M +378% 21 May 2025 10-Q 28 May 2025
Q1 2025 21.6M +17.4M +424% 30 Apr 2025 10-Q 16 May 2025
Q2 2024 4.51M +1.13M +33.3% 17 Jul 2024 10-Q 13 Aug 2024
Q1 2024 4.11M +733K +21.7% 31 Mar 2024 10-Q 24 Apr 2024
Q4 2023 3.75M -5.04B -99.9% 31 Dec 2023 10-Q 19 Jan 2024
Q3 2023 3.56M -5.03B -99.9% 06 Nov 2023 10-K 20 Nov 2023
Q2 2023 3.38M -4.97B -99.9% 30 Jun 2023 10-Q 25 Jul 2023
Q1 2023 3.38M -4.73B -99.9% 31 Mar 2023 10-Q 18 Apr 2023
Q4 2022 5.05B +484M +10.6% 17 Jan 2023 10-Q 19 Jan 2023
Q3 2022 5.03B 28 Oct 2022 10-K 15 Nov 2022
Q2 2022 4.97B +406M +8.9% 17 Jul 2022 10-Q 22 Jul 2022
Q1 2022 4.74B +990M +26.4% 07 Apr 2022 10-Q 21 Apr 2022
Q4 2021 4.56B 06 Dec 2021 10-K 22 Dec 2021
Q2 2021 4.56B 30 Jun 2021 10-Q 20 Jan 2022
Q1 2021 3.75B 14 May 2021 10-Q 18 Aug 2021
Q3 2019 571M 26 Aug 2019 10-Q 24 Oct 2019
Q4 2018 252M +106M +72.4% 31 Dec 2018 10-Q 12 Feb 2019
Q2 2018 159M +21.8M +15.9% 30 Jun 2018 10-Q 06 Aug 2018
Q1 2018 151M +13.2M +9.57% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 146M +768K +0.53% 31 Dec 2017 10-Q 06 Feb 2018
Q2 2017 137M +2.42M +1.8% 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 138M +9.86M +7.69% 31 Mar 2017 10-Q 05 May 2017
Q4 2016 145M +21.1M +17% 31 Dec 2016 10-Q/A 28 Apr 2017
Q3 2016 145M 30 Sep 2016 10-K/A 28 Apr 2017
Q2 2016 135M +20.6M +18.1% 30 Jun 2016 10-Q/A 28 Apr 2017
Q1 2016 128M +17.5M +15.8% 08 Apr 2016 10-Q/A 28 Apr 2017
Q4 2015 124M +72.2M +139% 29 Dec 2015 10-K/A 28 Apr 2017
Q2 2015 114M +62M +119% 01 Jul 2015 10-Q/A 28 Apr 2017
Q1 2015 111M +58.8M +113% 01 May 2015 10-Q/A 28 Apr 2017
Q4 2014 52M 09 Dec 2014 10-K 18 Dec 2014
Q2 2014 51.9M 02 Aug 2014 10-Q 07 Aug 2014
Q1 2014 51.9M 01 May 2014 10-Q 05 May 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.